Shanghai Medicilon Inc (688202) — Working Capital to Net Assets Ratio
Shanghai Medicilon Inc (688202) has a Working Capital to Net Assets ratio of 33.3% as of March 2026. Working capital of CN¥651.54 Million (current assets of CN¥1.35 Billion minus current liabilities of CN¥699.96 Million) is measured against net assets of CN¥1.96 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shanghai Medicilon Inc (688202) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Medicilon Inc Working Capital to Net Assets (2016–2025)
This chart shows how Shanghai Medicilon Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 33.3%, reflecting working capital of CN¥651.54 Million against net assets of CN¥1.96 Billion CNY. Check 688202 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shanghai Medicilon Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Medicilon Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688202 company net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 33.1% | CN¥640.37 Million | CN¥1.93 Billion | CN¥1.22 Billion | CN¥577.48 Million | ▼ -7.1 pp |
| 2024 | 40.2% | CN¥859.55 Million | CN¥2.14 Billion | CN¥1.44 Billion | CN¥576.15 Million | ▼ -7.2 pp |
| 2023 | 47.4% | CN¥1.19 Billion | CN¥2.51 Billion | CN¥1.88 Billion | CN¥686.36 Million | ▲ +19.0 pp |
| 2022 | 28.4% | CN¥455.59 Million | CN¥1.60 Billion | CN¥1.07 Billion | CN¥617.04 Million | ▼ -9.9 pp |
| 2021 | 38.3% | CN¥508.37 Million | CN¥1.33 Billion | CN¥892.04 Million | CN¥383.66 Million | ▼ -6.0 pp |
| 2020 | 44.3% | CN¥503.15 Million | CN¥1.14 Billion | CN¥699.29 Million | CN¥196.14 Million | ▼ -24.2 pp |
| 2019 | 68.5% | CN¥684.96 Million | CN¥1.00 Billion | CN¥799.02 Million | CN¥114.07 Million | ▲ +21.6 pp |
| 2018 | 46.9% | CN¥162.99 Million | CN¥347.89 Million | CN¥272.97 Million | CN¥109.99 Million | ▼ -8.3 pp |
| 2017 | 55.1% | CN¥158.43 Million | CN¥287.32 Million | CN¥243.49 Million | CN¥85.05 Million | ▼ -9.3 pp |
| 2016 | 64.5% | CN¥158.71 Million | CN¥246.09 Million | CN¥241.16 Million | CN¥82.45 Million | — |